Impact of an inpatient multidisciplinary glucose control management program

Arch Endocrinol Metab. 2018 Oct;62(5):514-522. doi: 10.20945/2359-3997000000071.

Abstract

Objective: Glycemic control has been increasingly recognized as a critical element in inpatient care, but optimal management of blood glucose in the hospital setting remains challenging. The aims of this study were to describe and evaluate the impact of the implementation of an inpatient multidisciplinary glucose control management program on glucose control in hospitalized patients.

Materials and methods: Retrospective analysis of medical records and glucose monitoring data obtained by point- of-care testing (POCT) in hospitalized patients before (May 2014) and after (June 2015 and May 2017) the implementation of the program.

Results: We analyzed 6888, 7290, and 7669 POCTs from 389, 545, and 475 patients in May 2014, June 2015, and May 2017, respectively. Hyperglycemia (≥ 180 mg/ dL) occurred in 23.5%, 19.6%, and 19.3% POCTs in May 2014, June 2015, and May/2017, respectively (p < 0.001), while severe hyperglycemia (≥ 300 mg/dL) was observed in 2.5%, 2.2%, and 1.8% of them, respectively (p = 0.003). Hyperglycemia (≥ 180 mg/dL) reduced significantly from May 2014 to June 2015 (16.3%, p < 0.001) and from May 2014 to May 2017 (178%, p < 0.001). No significant changes occurred in hypoglycemic parameters.

Conclusions: The implementation of an inpatient multidisciplinary glucose control management program led to significant reductions in hyperglycemic events. The key elements for this achievement were the development of institutional inpatient glycemic control protocols, establishment of a multidisciplinary team, and continuing educational programs for hospital personnel. Altogether, these actions resulted in improvements in care processes, patient safety, and clinical outcomes of hospitalized patients.

Publication types

  • Evaluation Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Blood Glucose / analysis*
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / prevention & control
  • Female
  • Humans
  • Hyperglycemia / drug therapy
  • Hyperglycemia / prevention & control*
  • Hypoglycemia / etiology
  • Hypoglycemic Agents / therapeutic use
  • Inpatients / statistics & numerical data*
  • Insulin / therapeutic use
  • Male
  • Middle Aged
  • Point-of-Care Testing / statistics & numerical data*
  • Program Evaluation
  • Reference Standards
  • Reproducibility of Results
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Treatment Adherence and Compliance

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin